rbcg-n-hrsv
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 27, 2017 (NCT03213405)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03213405 | Phase 1 | Jun 27, 2017 | Comisión Nacional de Investigación Científica y Tecnológica, Government of Chile, Millennium Institute on Immunology and Immunotherapy, Chile, Pontificia Universidad Catolica de Chile |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Comisión Nacional de Investigación Científica y Tecnológica | Government | 1 | 0 | 1 | 2017 |
| Government of Chile | Government | 1 | 0 | 1 | 2017 |
| Millennium Institute on Immunology and Immunotherapy, Chile | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Pontificia Universidad Catolica de Chile | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1